In vivo anti-CD3-driven cell activation: Cellular source of induced tumor necrosis factor, interleukin-1β, and interleukin-6

Transplantation

Volumn 61, Issue 1, 1996, Pages 83-87

  Goumy, Laurence ^a   Ferran, Christiane ^a   Merite, Sylvie ^a   Bach, Jean François ^a   Chatenoud, Lucienne ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; FC RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; MONOCLONAL ANTIBODY; OKT 3; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; INTERLEUKIN-1; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030051372     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199601150-00017     Document Type: Article

References (31)

1. Hirsch R, Gress RE, Pluznik DH, et al. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. J Immunol 1989; 142: 737.
2. Ferran C, Sheehan K, Dy M, et al. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur J Immunol 1990; 20: 509.
3. Ferran C, Dy M, Sheehan K, et al. Inter-mouse strain differences in the in vivo anti-CD3 induced cytokine release. Clin Exp Immunol 1991; 86: 537.
4. Alegre M, Vandenabeele P, Flamand V, et al. Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor. Eur J Immunol 1990; 20: 707.
5. Scott DE, Gause WC, Finkelman FD, Steinberg AD. Anti-CD3 antibody induces rapid expression of cytokine genes in vivo. J Immunol 1990; 145: 2183.
6. Yoshimoto T, Paul WE. CD4pos, NK1.1pos T cells promptly produce Interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 1994; 179: 1285.
7. Ferran C, Dautry F, Sheehan K, et al. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. J Clin Invest 1994; 93: 2189.
8. Durez P, Abramowicz D, Gerard C, et al. In vivo induction of IL-10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide - differential modulation by cyclosporin A. J Exp Med 1993; 177: 551.
9. Chatenoud L, Ferran C, Legendre C, et al. In vivo cell activation following OKT3 administration: systemic cytokine release and modulation by corticosteroids. Transplantation 1990; 49: 697.
10. Abramowicz D, Schandenne D, Goldman M, et al. Release of tumor necrosis factor, interleukin 2, and gamma interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 1989; 47: 606.
11. Ferran C, Dy M, Sheehan K, et al. Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-g, interleukin 3 and interleukin 6 release after triggering of the CD3/Tcell receptor activation pathway. Eur J Immunol 1991; 21: 2349.
12. Charpentier B, Hiesse C, Lantz O, et al. Anti-tumor necrosis factor monoclonal antibody prevents OKT3-induced acute syndrome. Transplantation 1992; 54: 997.
13. Van Wauwe JP, de Mey JR, Goossens JG. OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties. J Immunol 1980; 124: 2708.
14. 2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb. Transplantation 1990; 49: 1117.
15. Van Lier RAW, Boot JHA, de Groot ER, Aarden L. Induction of T cell proliferation with anti-CD3 switch variant monoclonal antibodies: effects of heavy chain isotype in monocyte dependent systems. Eur J Immunol 1987; 17: 1599.
16. Cuturi MC, Murphy M, Costa-Giomi MP, Weinmann R, Perussia B, Trinchieri G. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med 1987; 165: 1581.
17. Sung SSJ, Bjorndahl JM, Wang CY, Kao HT, Fu SM. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J Exp Med 1988; 167: 937.
18. Bette M, Schäfer M, van Rooïjen N, Weihe E, Fleischer B. Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen. J Exp Med 1993; 178: 1531.
19. Debets IMH, van der Linden CJ, Dieteren IEM, Leeuwen-Berg JFM, Buurman WA. Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes. J Immunol 1988; 141: 1197.
20. Krutmann J, Kirnbauer R, Köck A, et al. Cross-linking Fc receptors on monocytes triggers IL-6 production: role in anti-CD3-induced T cell activation. J Immunol 1990; 145: 1337.
21. Shirai A, Holmes K, Klinman D. Detection and quantification of cells secreting IL-6 under physiologic conditions in BALB/c mice. J Immunol 1993; 150: 793.
22. Kupper TS, Edwin A, Deitch EA, Baker CC, Wong W. The human burn wound as a primary source of interleukin-1 activity. Surgery 1986; 100: 409.
23. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481.
24. Sherry B, Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol 1988; 107: 1269.
25. Fong Y, Tracey KJ, Moldawer LL, et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1b and interleukin 6 appearance during lethal bacteriemia. J Exp Med 1989; 170: 1627
26. Clive Landis R, Friedman ML, Fisher RI, Ellis TM. Induction of human IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals. J Immunol 1991; 146: 128.
27. Williams JM, Deloria D, Hansen JA, et al. The events of primary T cell activation can be staged by use of sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1. J Immunol 1985; 135: 2249.
28. Geppert TD, Lipsky PE. Acivation of T lymphocytes by immobilized monoclonal antibodies to CD3. J Clin Invest 1988; 81: 1497.
29. Ceuppens JL, Baroja ML, Lorre K, Van Damme J, Billiau A. Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal. J Immunol 1988; 141: 3868.
30. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
31. Sheehan K, Ruddle NH, Schreiber RD. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 1989; 142: 3884.